semaglutide compounding news november 2025 Buying online? Here's what to know about pharmacies : Shots FDA crackdown on off-brand Ozempic

Oral semaglutide (Rybelsus) is already approved and marketed

These are trial-based exclusions and do not constitute established contraindications prior to MHRA authorisation: A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Severe gastrointestinal disorders such as gastroparesis Pregnancy or breastfeeding Significant renal or hepatic impairment (pending further safety data) UK patients interested in accessing retatrutide through a clinical trial should speak with their GP or a specialist obesity service

For some patients, medication may be the right choice

Well, if you look carefully, it doesnt really show any benefit to semaglutide either